Yvonne McGrath, Chief Scientific Officer at iTeos Therapeutics, Inc. (ITOS), sold 10,000 shares at $36.76 ($368K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Open-market sale of $368k ITOS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ITOS | SELL | 2021-06-03 | $348K | — | Filing → |
| ITOS | SELL | 2021-05-19 | $389K | — | Filing → |